STAT4 mediated modulation of T–B cell interactions profiling: enhances antitumor immunity in non-small cell lung cancer (NSCLC)

Key Points

• Enhancing antitumor immunity is crucial for effective treatment of non-small cell lung cancer.
• The study reports significant modulation of T-B cell interactions, suggesting potential therapeutic targets.
• Assessment using cellular profiling techniques shows increased immune responses against tumors in observed cases.
• This modulation of immune pathways highlights the need for further exploration into targeted therapies.